Doxorubicin down-regulated FLIP protein levels via reactive oxygen species, sensitizing cardiac myocytes to Fas-mediated apoptosis.
Doxorubicin sensitizes cardiac myocytes to Fas-mediated apoptosis by down-regulating the anti-apoptotic protein FLIP via a reactive oxygen species-dependent mechanism.
OBJECTIVE: Fas ligand (FasL) is a key cytokine which initiates apoptosis when FasL binds to its receptor, Fas. Cardiac myocytes are generally resistant to Fas-induced apoptosis. However, sublethal dose of doxorubicin (Dox) can sensitize cardiac myocytes to Fas-induced apoptosis. We investigated the molecular mechanism by which Dox sensitizes cardiac myocytes to Fas-induced apoptosis. FLICE inhibitory protein (FLIP) is a key molecule for blocking Fas-induced apoptosis by functioning as a caspase-8 dominant negative. METHODS AND RESULTS: FLIP was constitutively expressed in cultured neonatal rat cardiac myocytes. FLIP protein levels were markedly down-regulated by Dox in a time-dependent and dose-dependent manner. Next, we examined the relation of reactive oxygen species (ROS) by Dox to the expression of FLIP. Both of N-acetylcysteine (NAC) and the combination of superoxide dismutase and catalase restored the decreased FLIP in Dox-treated cardiac myocytes to the basal level. NAC also restored the increased formation of thiobarbituric acid-reactive substance after Dox-treatment. Concurrently, the susceptibility to Fas-mediated apoptosis disappeared with the treatments of the antioxidant agents. Hydrogen peroxide down-regulated FLIP in a dose-dependent fashion and also sensitized cardiac myocytes to Fas-induced apoptosis. CONCLUSIONS: FLIP, an inhibitor of apoptosis induced by cytokines of TNF family, contributes at least partly to Dox-induced sensitization to Fas-mediated apoptosis in cardiac myocytes. The expression of FLIP in cardiac myocytes is regulated by ROS.
Joji Nitobe (Sat,) conducted a other in Cultured neonatal rat cardiac myocytes. Doxorubicin vs. Untreated/basal level was evaluated on FLIP protein levels and susceptibility to Fas-mediated apoptosis. Doxorubicin down-regulated FLIP protein levels via reactive oxygen species, sensitizing cardiac myocytes to Fas-mediated apoptosis.